U.S.
EXCLUSIVE: Trump’s FDA nominee vows new abortion pill safety review after pressure from Sen Hawley
CRAYON summary
Fox News reports, in a piece labeled exclusive, that FDA commissioner nominee Dr. Heidi Overton has committed to a binding timeline for a long-delayed safety study of the abortion pill mifepristone. According to Fox News, the commitment was announced Friday by the office of Sen. Josh Hawley, and the outlet's headline describes it as coming after pressure from Hawley.
Based on Fox News's report - only one outlet has covered this so far. Read the original.▲ Sign in to vote stories up
Coverage 1 source · 1 report
Chronological.
-
EXCLUSIVE: Trump’s FDA nominee vows new abortion pill safety review after pressure from Sen Hawley
Food and Drug Administration nominee Dr. Heidi Overton committed to a timeline for a delayed mifepristone safety study, Sen. Josh Hawley's office says.
Discussion 0 comments